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Background: Bronchopulmonary dysplasia (BPD) is a common cause of respiratory insufficiency
in children born very premature.
Objectives: The purpose of this study was to examine the impact of the severity of BPD on
pulmonary morbidity at school age, as measured by conventional spirometry and impulse os-
cillometry. We also studied the association between changes in lung function and structural
changes in the lungs of children with BPD via High-Resolution Computed Tomography (HRCT).
Finally we studied the prevalence of atopy associated with BPD.
Methods: Westudied60very lowbirthweight (VLBW)children,28with respiratorydistress syndrome
(RDS)whodidnotdevelopBPD("pretermnon-BPD")and32withRDSwhodevelopedBPD.Theseverity
of BPDwas graded asmild, moderate or severe. Follow-up at age 6e8 years consisted of spirometry,
oscillometry, thoracic HRCT, allergy skin-prick test, blood samples and a questionnaire.
Results: All childrenwithBPD showed someevidenceof impaired lung function (more negative reac-
tance, FEV1< 80% predicted, greater reversibility), although less than half of these children were
symptomatic. The majority of children with BPD (19/26) showed abnormalities on HRCT. There
was no evidence that atopy was associated with BPD.
Conclusions: ChildrenwithmildBPDexhibited similar impairments in respiratorymechanicsand lung
structure to those diagnosed with moderate BPD. The widespread involvement of the peripheral
airways suggests that all children diagnosed with BPD are potentially at risk of developing chronic
obstructive pulmonary disease later in life.
ª 2009 Elsevier Ltd. All rights reserved.t H2 O2, Karolinska University Hospital, S-171 76 Stockholm, Sweden. Tel.: þ46 70 540 77 61 fax: +46
trom@karolinska.se (E.B. Brostro¨m).
9 Elsevier Ltd. All rights reserved.
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Figure 1 Schematic description of the recruitment into the
study.
Obstructive lung disease in children with BPD 363Introduction
Bronchopulmonary dysplasia (BPD) is a common cause of
respiratory insufficiency in children born very prema-
ture.1,2 Despite the fact that the severity of BPD has
declined over the past decade, the disease still leads to
considerable long-term impairment of respiratory func-
tion.3e5 Sequelae in childhood may be further aggravated
by exposure to second-hand-smoking and/or by atopy.
Over the longer term, infants with BPD may be at increased
risk of developing chronic obstructive pulmonary disease
(COPD) in adulthood.6e12 Thus, systematic follow-up
programs that include measurement of lung function are
necessary to determine the severity of long-term lung
impairment and to evaluate the efficacy of medical
treatments. In this study, we examined the link between
the severity of BPD in infancy and pulmonary morbidity at
school age, as measured by conventional spirometry and
impulse oscillometry. While both methods are non-invasive
and require no sedation, the oscillometric method
measures lung function during normal tidal breathing.
Because it requires only minimal cooperation from the
patient5e14 compared with routine spirometry15 oscillom-
etry is particularly suitable for evaluating small children.
Unfortunately, only a few studies have evaluated the
concordance between the oscillometric and spirometric
methods.16e18
When investigating the long-term effects of BPD, non-
invasive imaging is valuable for identifying structural
changes in the lung. High-resolution computed tomography
(HRCT) is better at detecting these abnormalities than
chest radiography, but its use in children with BPD is not
widespread. Publications on this topic do, however, reveal
pathological changes in the majority of the infant lungs
examined.19e23 Since children with BPD have similar clin-
ical symptoms to children with asthma, the question of
whether there is a correlation between BPD and atopy
arises. Recent studies suggest that children with BPD do
not have an increased prevalence of atopy (as do children
with asthma).24e26
We hypothesized that: 1) the severity of BPD is the
major factor determining whether respiratory abnormali-
ties are present at school age; 2) findings based on oscill-
ometry and spirometry may not agree because each
technique describes different but complementary aspects
of lung function; 3) there is an association between func-
tional impairment and structural lung changes in children
with BPD; and4 4)BPD is not associated with a higher
prevalence of atopy at school age.
Materials and methods
Subjects
The study group consisted of 60 very low birth weight
(VLBW) children, 28 with respiratory distress syndrome
(RDS)27 who did not develop BPD (preterm non-BPD group)
and 32 with RDS and BPD. Mechanical ventilation and
surfactant administration was initiated if the PCO2 excee-
ded 8.5 kPa, FiO2> 0.8 or BE10 with signs of severe
respiratory distress.Those who did not develop BPD comprised a group
against which the impact of BPD on lung function was
compared. All children had been treated at the Neonatal
Care Unit of Sachsska Children’s Hospital between 1992 and
1997. For details, see Fig. 1.
The diagnosis of BPD was based on the need for
supplementary oxygen at 28 days of age. The severity of
BPD was determined at 36 weeks gestational age (GA) as
follows: 1) breathing air - mild BPD; 2) need for supple-
mentary oxygen (less than 30%) - moderate BPD; 3) 30%
supplementary oxygen and/or continuous positive airway
pressure (CPAP) or ventilator - severe BPD.28
Parents were fully informed about the purpose and
procedures of the study and written informed consent was
obtained. The study was approved by the Local Ethics
Committee.
Perinatal and neonatal data included: treatment with
prenatal steroids, GA at birth, birth weight (BW), instilla-
tion of surfactant, chest radiography at age 1 month,
number of days on a ventilator, CPAP and supplemental
oxygen.
Follow-up at 6e8 years
The questionnaire included questions about asthma, hay
fever, eczema, the frequency of airway infections during
the previous year, symptoms of airway hyper-reactivity,
medical treatments, feeding difficulties, family history of
atopy, and smoking habits of the family and the mother
during pregnancy.
Physical examination: included measurements of body
weight and height, allergy skin-prick test, blood samples,
spirometry and oscillometry. Our Ethics Committee only
granted approval for the BPD group to be scanned by HRCT.
364 E.B. Brostro¨m et al.None of the children had respiratory infections at the time
of the lung function tests. b2-agonists were withdrawn 12 h
beforehand. Atopy was defined as one or more positive
skin-prick test results, defined as a weal with diameter
3 mm. The test panel involved 13 allergens: Alternaria,
Cladosporium, Dermatophagoides farinae, Dermatopha-
goides pteronyssinus, dog, horse, rabbit, cat, birch,
timothy, mugwort, hen’s egg white, peanut. Histamine
chloride (10 mg/ml) was the positive control and the
allergen diluent was the negative control. Blood samples
were taken and analyzed for eosinophil cation protein
(ECP), IgA, IgG, IgM, and for airway and food allergens
(Phadiatop; Phadia, Uppsala, Sweden).
Pulmonary function
Impulse oscillometry (IOS; Jaeger Masterscreen,
W}urzburg, Germany) was used to measure the input
impedance of the respiratory system. The impulse interval
was set to 0.3 s.29 The reference values of Malmberg were
used.30 The pneumotachograph was calibrated daily
before the use. The output pressure and flow signals were
analyzed for resistance (Rrs) and reactance (Xrs), the two
components of the respiratory impedance (Zrs). Reactance
is characterized by negative values i.e. the more negative
the value the more pronounced is small airway dysfunc-
tion. The resonance frequency (fres Hz; the frequency at
which Xrs is zero) was also calculated. The IOS measure-
ments were performed with the child in a sitting position
during tidal breathing. A nose clip was used and the cheeks
were supported by the parent or investigator during
measurements. A minimum of 20 s of regular breathing
without sudden changes in online impedance was required.
At least three measurements were performed and of
these, three reproducible measurements were used to
calculate mean values of Rrs and Xrs at an oscillation
frequency of 5e35 Hz.
Dynamic spirometry to produce flow-volume curves was
performed using a pneumotachograph (Vitalograph).
Spirometry was done directly after the IOS measurement. A
nose clip was used and the child performed the exhalation
in a sitting position. At least three acceptable flow-volume
curves were obtained according to the reproducibility
criteria of the European Respiratory Society.31 Forced vital
capacity (FVC), forced expiratory volume at one second
(FEV1), the ratio FEV1/FVC (FEV%) and mid-expiratory flow
at 75e25% of FVC (FEF75e25) were recorded. Values of Pol-
gar and Promadhat were used as reference data.32
Reversibility test: inhalation of 5 mg salbutamol by
nebulizer (Ailos, Sweden) was given to the patient. Fifteen
minutes after administration of the b2-agonist, IOS and
spirometry was repeated.
High-resolution computed tomography
(HRCT) of the thorax
HRCT scans were performed on a four detector CT
scanner (Siemens Volume Zoom) at 120 kV and 88e102 mA
(depending on weight of the child) and a scanning time of
0.75 s. Approximately 20 HRCT images at 1.25 mm slice
thickness and 10 mm intervals were evaluated. HRCTscans performed before 2002 were on a single detector
CT scanner (HiSpeed Advantage, GE Healthcare) at
120 kV, 90 mA and a scanning time of 1.0 s. 10 HRCT
images at 1 mm slice thickness and 10 mm intervals were
evaluated.
Only two children required sedation during the
examination.
Data analysis
 Differences between respiratory measurements of
preterm non-BPD group and BPD groups were tested
using Kruskal-Wallis analysis of variance and displayed
graphically as Box-and-Whisker plots.
 Possible correlations between spirometric and IOS
measurements were analyzed using linear regression
analysis. The analysis comprised the entire study pop-
ulation i.e. no subgroup analysis was performed.
 Multiple regression analysis was used to analyze the
influence of a variety of independent risk factors such
as birth weight, gestational age at birth, days of oxygen
treatment, steroids (systemic and inhaled), smoking
and BPD on spirometric/IOS parameters. A forward
stepwise regression was carried out to find factors that
significantly contributed to variance.
P-values of <0.05 were considered significant.
Results
Perinatal and neonatal data
Of the total 60 children, 32 had BPD, of whom 20 were
graded as mild, 8 as moderate, and 4 as severe BPD. The
patient data are presented in Table 1a. The average BW and
the GA of children with BPD was significantly lower than
those without BPD. Children with mild, moderate or severe
BPD were of similar BW and GA. The severity of BPD was
positively correlated to days on a ventilator, CPAP and
duration of days on supplemental oxygen.
Note that in the moderate group one child had supple-
mentary oxygen for 28 days due to a ‘‘late onset’’ of need
for oxygen, and the need for supplementary oxygen still at
36th week, therefore he was considered having moderate
BPD. The min for the rest of the moderate group was
61 days.
Health status and symptoms at school age
There were no differences between age, height, weight and
parental smoking habits at follow-up of children with and
without BPD (Table 1b). Follow-up data on respiratory
symptoms and medical treatments are provided in Table 2.
None of the children were on systemic steroids. Only 1
infant in each group required hospitalization.
The prevalence of allergy among parents of BPD and
non-BPD children was comparable (22/32 and 16/28
respectively, pZ 0.35). On the other hand, significantly
more parents of children with BPD suffered from asthma
(16/32 and 7/28 respectively, pZ 0.047).
Table 1 Population data e neonatal and follow-up data (60 infants).
Non-BPD
Median
(minemax)
nZ 28
BPD
MildZ 1
Median
(minemax)
nZ 20
BPD
ModerateZ 2
Median
(minemax)
nZ 8
BPD
SevereZ 3 Median
(minemax)
nZ 4
Significance level
p values
a
Gestational age at
birth (weeks)
30
(28e31)
27
(24e30)
27,5
(25e30)
28
(25e29)
<0.000
Non-BPDs BPD1e3
Birth weight (g) 1495
(845e2094)
987,5
(654e1520)
1133
(597e1252)
905
(775e1210)
<0.000
Non-BPDs BPD1e3
Instillation of surfactant 1 1 3 2 ns
Ventilatory therapy e
duration (days)
0
(0e5)
0
(0e34)
3,5
(0e38)
23
0e33)
<0.000
Non-BPDZ BPD1s 2e3
CPAP eduration (days) 3,5
(0e18)
31,5
(4e70)
32
(3e55)
32,5
(13e60)
<0.000
Non-BPDs BPD1e3
Suplemental O2 eduration
(days)
3
(0e26)
55
(29e83)
71,5
(28*e96)
141
(105e180)
<0.000
Non-BPDs BPD1s BPD2s BPD3
Smoking
During pregnancy 8 3 3 4 Non-BPDZ BPD
In home environment 8 5 3 4
Any exposion 9 6 4 4
Costicosteroids therapy
Prenatal 18 13 5 2 Non-BPDZ BPD
Systemic- postnatal 0 1 0 0 Non-BPDZ BPD
b
Smoking
During pregnancy 8 3 3 4 Non-BPDZ BPD
In home environment 8 5 3 4
Any exposion 9 6 4 4
Costicosteroids therapy
Inhalation 0 12 6 4 Non-BPDs BPD <0.000
Systemic 0 0 0 0
Age at test (months) 91
(78e97)
88,5
(76e99)
87
(79e95)
85,5
(83e90)
ns
0.16
Height at test (cm) 127
(112e138)
124
(105e145)
120,5
(111e130)
122,5
(114e128)
ns
0.08
Weight at test (kg) 23,5
(19e31)
22
(15e42)
22
(17e29)
24
(19e26)
ns
0.78
 GA at birth e significantly higher in Non-BPD, no differences between BPD.
 Birth weight - significantly higher in Non-BPD, no differences between BPD.
 Ventilator (days) - BPD grade 2 and 3 similar, different from BPD grade 1 and Non-BPD.
 CPAP (days) - significantly lowest in Non-BPD, no differences between BPD.
 Suppl. O2 e significant differences among ALL groups, highest in BPD 3.
* see explanation in the Results.
Obstructive lung disease in children with BPD 365Lung function tests
The majority of children performed spirometry and oscill-
ometry without difficulty although the IOS measurements
for one child were inconclusive.
Since there were no significant differences between IOS,
spirometry and reversibility results for children with mild
and moderate BPD, pulmonary function data for these two
groups were pooled and are presented as one entity (mild-
moderate BPD).
Differences between spirometry/IOS results for children
with and without BPD remained significant after adjust-
ment for gestational age and birth weight. BPD was the
strongest independent variable influencing lung function,contributing 16e40% to variability (Multiple Regression
Analysis).
IOS
In general for children with severe BPD there was evidence
of deterioration in lung function in all parameters tested
(Table 3).
Spirometry
There were significant differences between preterm non-
BPD group and children with mild-moderate and severe BPD
for all parameters tested. Fig. 2 shows the results for all
Table 2 Follow-up data on respiratory symptoms, medical
treatments and feeding difficulties.
Non-BPD BPD Significance
leves
Respiratory symptoms 5/28 15/32 pZ 0.02
>5 episodes with
respiratory
symptoms last year
1/28 5/32 pZ 0.12
Asthma (as diagnosed
by their doctor)
1/28 6/32 pZ 0.07
Continuous inhalations
with steroids
0/28 8/32 pZ 0.005
Treatment with
b2-agonists
and steroids
0/28 5/32 pZ 0.03
Treatment with
Montelucast
0/28 2/32 pZ 0.19
Feeding difficulties 1/28 6/32 pZ 0.07
366 E.B. Brostro¨m et al.four groups. Since there was no difference between mild
and moderate BPD, the results for these groups are pooled
together in Table 3.
Significantly more children with BPD had an FEV1 below
80% predicted (p< 0.001). Only 8 of these 19 children
described respiratory symptoms.
Reversibility test
A 10% increase in FEV1 has been used as a positive result in
the reversibility test. The most marked reversibility was
found in children with severe BPD, followed by those with
mild-moderate BPD and preterm non-BPD group (50%, 29%
and 21% respectively). At the group level, irrespective of
the severity of BPD, there was negative correlation
between FEV1% predictive and reversibility expressed in
percent (pZ 0.00, corr. coffecientZ0.52; see Fig. 3).
Concordance between spirometry and IOS
In absolute terms, there was a significant correlation
between FEV1 and resistance and reactance at 5e10 Hz
(p< 0.002, rZ 0.43e0.79) i.e. a low FEV1 was associated
with high resistance and high (more negative) reactance.
There was better agreement for resistance at 5 Hz and FEV1
(p< 0.0003, rZ 0.79) than for the reactance values.
Normalized values were tested using standard deviation
(SD) for R and X at 5e10 Hz and percentage predicted FEV1,
(pZ 0.004, rZ0.37).
Second-hand smoking and lung function
The prevalence of antenatal and/or postnatal exposure to
cigarette smoke (second-hand smoking, SHS) was compa-
rable between children with and without BPD. Twenty-
three of 60 children were exposed to cigarette smoke
either during fetal life or after delivery (Table 1). Fifteen
mothers smoked during the entire pregnancy, and 3
stopped smoking during the first trimester. After delivery,20 mothers either continued or resumed smoking. Children
exposed to SHS had a significantly lower FEV1% pred, FEV1,
FVC, and FVC % (pZ 0.04, 0.05, 0.01, and 0.01, respec-
tively) compared with non-exposed children. Respiratory
reactance (Xrs5 and Xrs10) was also significantly higher
(more negative) in smoke-exposed children (pZ 0.02 and
0.02, respectively).
Immunology and atopy
Four children (2 in each group) refused to provide blood
samples. ECP levels were not associated with spirometric
findings (pZ 0.28e0.95), or with the severity of BPD
(pZ 0.21). Six BPD and 5 control children refused a skin-
prick test. Positive skin-prick tests were rare in both groups
(5/23 and 3/21 in the control and BPD groups, respec-
tively), as were positive Phadiatop tests (5/22 and 1/27 in
the control and BPD groups; pZ 0.04). Parental asthma did
not affect a child’s FEV1%pred. The children with clinical
respiratory symptoms (wheezing, tachypne, retractions)
did not differ with respect to FEV1%pred from those who
were asymptomatic.
There was a correlation between low FEV1% pred and
low levels of IgG (pZ 0.02), but no correlation between
FEV1% pred and other immunological parameters.
Radiological findings
Twenty-five out of 32 chest radiographs taken at 1 month
of age showed abnormalities. At follow-up at 6e8 years
4 families declined examination by HRCT and 2 had moved
from the area of Stockholm. Of the total 26 successful
HRCTs, 7 were normal, whilst 19 children showed minor
abnormalities such as fibrosis, emphysema (10 children),
bronchial wall thickening (2 children), and/or linear opac-
ities (10 children). In mild BPD, 10/15 scans showed some
abnormalities. In the moderate BPD group the proportion
was 5/7, and in severe BPD emphysema was diagnosed in all
children. Of the 19 children with abnormal scans, 11 had
a FEV1< 80% pred.
Discussion
Children born premature, particularly those diagnosed with
BPD, show increased morbidity during early childhood.33
Studies have repeatedly demonstrated early impairment of
lung function which may vary in severity during follow-up to
adulthood. In the present study, we found reduced lung
function at 6e8 years of age in children born premature
who subsequently developed BPD. Functional lung impair-
ment was most pronounced in severe BPD, but children with
mild-moderate BPD also differed significantly from preterm
non-BPD group. To assess the impact of BPD on lung func-
tion, our comparison group deliberately comprised preterm
children with RDS that did not progress to BPD (preterm
non-BPD group). Our study was not designed to evaluate
whether preterm non-BPD group differed from healthy
children born at term. In many follow-up studies, children
with mild BPD have either been excluded or combined with
preterm non-BPD group. The rationale for this was that the
‘‘old’’ definition of BPD was based on the need for
Table 3 Respiratory measurements with IOS and standard spirometry in children with BPD and non-BPD. The values represent
medians (min-max).
Non-BPD BPD
MildZ 1
ModerateZ 2
BPD
SevereZ 3
p values
IOS
Rrs 5 Hz kPa l1 s1 0.7
(0.5e1.0)
0.8
(0.5e1.3)
1.0
(0.7e1.1)
0.01
Non-BPDs BPD1e2s BPD3
Rrs 10 Hz kPa l1 s1 0.6
(0.5e0.9)
0.7
(0.4e1.1)
0.9
(0.6e1.0)
0.03
Non-BPDZ BPD1e2s BPD3
Rrs 15 Hz kPa l1 s1 0.6
(0.4e0.8)
0.6
(0.4e0.9)
0.8
(0.5e0.9)
ns
0.06
Rrs 20 Hz kPa l1 s1 0.5
(0.4e0.7)
0.6
(0.3e0.8)
0.7
(0.46e0.8)
ns
0.08
Xrs 5 Hz kPa l1 s1 0.2
0.4 to 0.2
0.2
0.5 to 0.1
0.4
0.4 to 0.3
0.03
Non-BPDZ BPD1e2s BPD3
Xrs10 Hz kPa l1 s1 0.1
0.3 to 0.01
0.1
0.3 to 0.0
0.2
0.2 to 0.1
0.01
Non-BPDZ BPD1e2s BPD3
Fres l/s 17
10e21
19
11e25
23
19e28
<0.005
Non-BPDZ BPD1e2s BPD3
Zrs 5 Hz kPa l1 s1 0.7
(0.5e1.1)
0.8
(0.5e1.4)
1.1
(0.8e1.2)
0.01
Non-BPDs BPD1e2s BPD3
Spirometry
FEV1L 1.5
1.1e2.1
1.2
0.8e1.9
0.9
0.7e1
<0.00
Non-BPDs BPD1e2s BPD3
FEV1%pred 95.4
75e111
81
61e97
68
44e71
<0.00
Non-BPDs BPD1e2s BPD3
FVC L 1.8
1.2e2.6
1.4
0.9e2.1
1.1
1e1.2
<0.00
Non-BPDs BPD1e2s BPD3
FVC %pred 98
78e129
85
66e109
74
54e89
<0.00
Non-BPDs BPD1e2s BPD3
FEV1L/FVCL 0.9
0.7e0.98
0.89
0.62e0.99
0.76
0.7e0.88
ns
0.08
FEF 25e75% 93
44e123
66
31e107
42
19e123
<0.00
Non-BPDs BPD1e2s BPD3
Reversibility tests
FEV1%rev 3.5
0e22
8.2
0e24
12.4
1.4e30
0.04
Non-BPDs BPD1e2Z BPD3
FEF 50%rev 8.7
0e107
25
3 to 96
38
13e72
0.01
Non-BPDs BPD1e2Z BPD3
FEV 25e50%rev 13
0e126
23
0e114
38
1.5 to 62
ns
0.07
Rrs 5 Hz rev 21
0e39
26
0e46
24
12e35
ns
0.7
Obstructive lung disease in children with BPD 367supplementary oxygen at 36 weeks of GA. Our results,
however, demonstrate that even children with mild BPD
exhibit significant pulmonary dysfunction, and emphasize
the need for careful diagnosis and follow-up of these chil-
dren as a separate group.
Our study shows agreement between respiratory
measurements performed by oscillometry and spirometry.
Oscillometry is useful in identifying airway dysfunction e.g.
bronchial obstruction, bronchial hyper-reactivity, and
bronchodilator responsiveness,1 and has the advantage of
allowing measurements to be made during spontaneous
tidal breathing. Moreover, because it requires minimal
cooperation, oscillometry is ideally suited for childrenyounger than 5 years, who are often difficult to study by
conventional spirometry.
Impulse oscillometry
Our oscillometric findings - high resistance, and high (more
negative) reactance for children with BPD - agree with
published data. Malmberg et al. used the same impulse
oscillometric system and studied children at the same
age.14 Like us, they found that oscillometry could differ-
entiate children with and without BPD.
Our study further demonstrates that reactance at low
frequencies is a highly sensitive marker of lung dysfunction
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Figure 2 Spirometric measurements of FEV1% predicted and
FEV25e75% predicted values in children at school age who
suffered from neonatal lung disease of different grades. Notice
the pronounced differences between the groups. Box-and-
Whisker plot: the medians are presented as bold horizontal
lines, the rectangles contain 50% of the values, the bars extend
out to the minimum and the maximum values and the outlying
values are presented as dots.
368 E.B. Brostro¨m et al.in prematurely born children, and may in fact differentiate
the severity of BPD. Theoretically, reactance is mainly
determined by peripheral obstruction and the elastic
properties of the lung parenchyma, both of which are
features of BPD. In our study, X10 was most negative in
children with severe BPD. Thus X10 is a sensitive marker of
lung changes after premature birth and may identify those
children at risk of developing COPD.
In the present study the resistance at low frequencies
was elevated in children with BPD. This finding contrastsR
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Figure 3 Association between individual FEV1% predicted
and reversibility (%) in the entire study population. The results
show that children with most pronounced obstructivity were
most sensitive to treatment with b2-agonists.with recent data that suggested resistance was comparable
but reactance and resonance frequency differed between
children with and without BPD.5
Spirometry
Forced vital capacity (FVC % predicted) was within the
normal range for our ‘‘control’’ children but was reduced in
mild to severe BPD. This finding agrees with other studies
that have demonstrated more-or-less normal lung volumes
in healthy prematurely born children but slightly lower
forced volumes in those with BPD. The reduction in FVC%
could be due to restrictive lung function impairment and/or
hyperinflation. FEV1 is the most commonly used marker of
obstructive lung disease and deteriorates slowly in
progressive lung diseases such as COPD. Several follow-up
studies on BPD at various ages have shown that FEV1 may lie
within the normal range (>80% predicted) but be slightly
lower than in healthy controls.3,35,36 We found that FEV1
was significantly reduced in children with BPD. More
importantly, at 6e8 years of age, half of the children with
BPD had a FEV1 below the normal range, compared with
only about one-sixth of our preterm non-BPD group. This
finding is consistent with data from others showing that BPD
is associated with mild-to-moderately reduced lung func-
tion in early adulthood.6,37 One study has, however, sug-
gested the contrary: that there is some improvement in
lung function between 7e10 years of age.38
Concordance between spirometry and IOS
Agreement between IOS and other methods of testing
airway function has been described for asthma and BPD.14
Malmberg et al. found the best association between FEV1
and X5 in a group of prematurely born children, some of
whom had BPD. This is consistent with our findings as well
as studies of asthmatic children.16,34
On the basis of our results we conclude that both
methods are useful for diagnosing obstructive disease
although each describes different aspects of lung function
(see below).
Reversibility test
Increased motor tone in bronchial smooth muscle has been
shown in follow-up studies of BPD graduates.6,37,38 Our data
demonstrate significantly greater reversibility for children
with BPD compared with preterm non-BPD group, with the
greatest response seen in children with the most severe
BPD. Oscillometry, on the other hand, failed to demon-
strate reversibility differences between children with and
without BPD.5 Because reversibility can be detected by
oscillometry in asthmatic patients,35 it has been suggested
by Vrijlandt et al., that airway damage may be more
peripheral in BPD compared with asthma.5
HRCT findings
Pulmonary abnormalities were found in 72% of the children
diagnosed with BPD during the neonatal period, with nearly
50% of these also suffering from emphysema. Because
Obstructive lung disease in children with BPD 369emphysema results from disturbed alveolar and vascular
development,39 these children may be at risk of eventually
developing COPD. Interestingly, most children with mild
BPD (67%) showed similar anomalies to those with more
severe forms of BPD.
Atopy
Children with BPD had respiratory symptoms, were classi-
fied as ‘‘asthmatic’’ and were treated with inhalation
steroids and/or b2-agonists to a much greater extent than
controls. With regard to markers of atopy (ECP, positive
skin-prick tests and positive Phadiatop), there were no
differences between preterm non-BPD group and children
with BPD. The prevalence of allergy among parents of these
children was also comparable, although parents of children
with BPD were more often asthmatic. Other studies have
reported conflicting findings regarding the inheritance and
prevalence of asthma in children with BPD.26 These chil-
dren have a different phenotype from that classically seen
in atopic asthma, with normal levels of ECP and low prev-
alence of atopy. The higher prevalence of parental asthma
in this group may reflect a hyper-reactive airway rather
than atopy per se.
Conclusion
Our study reveals functional and structural pulmonary
impairment but no signs of atopy in children suffering from
mild as well as moderate and severe BPD. We found more
marked impairment at the severe end of the BPD spectrum.
The long-term importance of these changes, which include
reduced FEV1 and an abnormal IOS result, is not yet clear.
The abnormal IOS result we and others have reported may
reflect peripheral and possibly more widespread airway
impairment, as also suggested by HRCT. From a clinical
perspective, these children (especially those most severely
affected) could be at high risk of developing chronic lung
disease later in life. There have been few, if any, prospective
studies on treatment and other interventions after the
neonatal period. Functional and imaging techniques that can
differentiate the more severe from milder forms of airway
impairment could play an important role in the early eval-
uation of preschool children with BPD. Early and accurate
evaluation may lead to improved intervention and treatment
to reduce the risk of further deterioration. Clearly, all chil-
dren with BPD, regardless of its severity, should be followed
clinically. More detailed long-term follow-up is needed to
characterize the pulmonary sequelae, improve treatment
and reduce the incidence of COPD.
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